扶桑薬品工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2020/11/06 | 日証協 | 34,420株 | +4.56% | 4,694株 | -50.06% | 54,232株 | +3.63% | 8,000株 | +60% |
2020/10/30 | 日証協 | 32,920株 | +13.13% | 9,400株 | +202.35% | 52,333株 | +4.81% | 5,000株 | +47.02% |
2020/10/23 | 日証協 | 29,100株 | -6.16% | 3,109株 | +29.54% | 49,933株 | +0.61% | 3,401株 | +70.05% |
2020/10/16 | 日証協 | 31,011株 | +3.47% | 2,400株 | -87.27% | 49,632株 | -1.31% | 2,000株 | -88.63% |
2020/10/09 | 日証協 | 29,971株 | +75.16% | 18,860株 | +71.14% | 50,292株 | +14.29% | 17,589株 | -13.54% |
2020/10/02 | 日証協 | 17,111株 | +41.08% | 11,020株 | +400.91% | 44,003株 | +18.5% | 20,343株 | +57.7% |
2020/09/25 | 日証協 | 12,129株 | -56.68% | 2,200株 | -65.24% | 37,132株 | -29.32% | 12,900株 | +437.5% |
2020/09/18 | 日証協 | 28,000株 | -9.15% | 6,329株 | -11.11% | 52,532株 | -2.05% | 2,400株 | -62.5% |
2020/09/11 | 日証協 | 30,820株 | -15.14% | 7,120株 | +7.88% | 53,632株 | -3.07% | 6,400株 | -24.35% |
2020/09/04 | 日証協 | 36,320株 | +2.43% | 6,600株 | +312.5% | 55,332株 | -0.97% | 8,460株 | +1310% |
2020/08/28 | 日証協 | 35,460株 | +2.01% | 1,600株 | -75% | 55,872株 | +2.76% | 600株 | -85.71% |
2020/08/21 | 日証協 | 34,760株 | +1.76% | 6,400株 | +300% | 54,372株 | -4.9% | 4,200株 | +5% |
2020/08/14 | 日証協 | 34,160株 | -13.65% | 1,600株 | -86.53% | 57,172株 | -1.89% | 4,000株 | -26.99% |
2020/08/07 | 日証協 | 39,560株 | -0.2% | 11,879株 | +86.22% | 58,272株 | +6.39% | 5,479株 | +36.26% |
2020/07/22 | 日証協 | 40,160株 | +6.08% | 2,300株 | -56.6% | 55,272株 | +2.02% | 2,100株 | -19.23% |
2020/07/17 | 日証協 | 37,860株 | -9.9% | 5,300株 | +12.77% | 54,177株 | -6.17% | 2,600株 | +115.77% |
2020/07/10 | 日証協 | 42,020株 | +0.05% | 4,700株 | +106.23% | 57,737株 | +4.16% | 1,205株 | -88.19% |
2020/07/03 | 日証協 | 41,999株 | -1.46% | 2,279株 | -56.17% | 55,432株 | +10.13% | 10,200株 | +54.55% |
2020/06/26 | 日証協 | 42,620株 | +4.92% | 5,200株 | +898.08% | 50,332株 | -7.53% | 6,600株 | +56.18% |
※株式分割は考慮していませんのでご注意ください。